FORMULATION AND EVALUATION OF MOUTH-DISSOLVING ORAL FILM OF NICOTINE USING QUALITY BY DESIGN APPROACH
DOI:
https://doi.org/10.22159/ijap.2025v17i4.53880Keywords:
Nicotine, Extraction, OFDF, Powder characterization, SEM, XRDAbstract
Objective: Nicotine is a natural alkaloid found in Nicotiana tabacum and is widely used as a potent stimulant. This study aims to extract and characterize nicotine from tobacco powder and formulate a nicotine-containing Oral Fast-Dissolving Film (OFDF) for nicotine replacement therapy.
Methods: Nicotine was extracted from tobacco using water and Hydrochloric Acid (HCL). Purification was performed using column chromatography. The extracted nicotine was characterized using UV-visible spectroscopy, XRD, SEM, and FTIR. The OFDF was prepared using a Quality by Design (QbD) approach; a factorial design 3x3 was employed for film optimization. The solvent casting method was used for film preparation. The optimized formulation was evaluated for folding endurance, disintegration time, and drug release. Stability studies were performed as per ICH guidelines.
Results: The extraction process successfully yielded purified nicotine in crystalline form, having a crystalline index of 88.89%. The extracted nicotine shows lambda max at 260 nm; the FTIR study confirms the stretching and bending vibration frequencies for nicotine. The polymer Hydroxypropyl Methylcellulose (HPMC-E5) and plasticizer Polyethylene Glycol (PEG) concentrations (w/w) were selected as independent variables. At the same time, disintegration time, folding endurance, and dissolution time were evaluated as dependent variables for QbD. All the formulations were assessed, and FF3 is the optimized batch based on the dissolution, drug content, and folding endurance.
Conclusion: Nicotine was extracted and purified. The purified nicotine was then incorporated into an OFDF, which exhibited rapid disintegration and dissolution. This formulation can aid patients experiencing nicotine withdrawal symptoms by providing a safer, immediate nicotine release.
References
Feng K, Liu C, Zhang S, WU J, Eleuteri AM, Bai Y. Insights into the formation of pullulan nanofilm and its feasibility as probiotic resided oral fast-dissolving carrier. Int J Biol Macromol. 2025 Apr;299:140091. doi: 10.1016/j.ijbiomac.2025.140091, PMID 39842598.
LI Y, Zhao M, Zhao MY, LI B, Tian JL. Advances in oral dissolving film research in the food field. Food Prod Process Nutr. 2025;7(1):1-15. doi: 10.1186/S43014-024-00285-X.
Borges JG, DE Carvalho RA. Orally disintegrating films containing propolis: properties and release profile. J Pharm Sci. 2015 Apr.;104(4):1431-9. doi: 10.1002/JPS.24355, PMID 25631489.
Castro PM, Fonte P, Sousa F, Madureira AR, Sarmento B, Pintado ME. Oral films as breakthrough tools for oral delivery of proteins/peptides. J Control Release. 2015 Aug;211:63-73. doi: 10.1016/j.jconrel.2015.05.258, PMID 25979328.
View of formulation development of oral fast-dissolving films of rupatadine fumarate. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/39185/23832. [Last accessed on 10 Mar 2025].
Sevinc Ozakar R, Ozakar E. Current overview of oral thin films. Turk J Pharm Sci. 2021;18(1):111-21. doi: 10.4274/tjps.galenos.2020.76390, PMID 33634686.
Duren M, Atella L, Welding K, Kennedy RD. Nicotine pouches: a summary of regulatory approaches across 67 countries. Tob Control. 2023 Feb 7;tc-2022-057734. doi: 10.1136/tc-2022-057734, PMID 36750358.
Kasza KA, Tang Z, Seo YS, Benson AF, Creamer MR, ED wards KC. Divergence in cigarette discontinuation rates by use of electronic nicotine delivery systems (ENDS): longitudinal findings from the United States PATH study waves 1-6. Nicotine Tob Res. 2025 Jan;27(2):236-43. doi: 10.1093/NTR/NTAE027, PMID 38566367.
XU LL, Shi LL, Cao QR, Xu WJ, Cao Y, Zhu XY. Formulation and in vitro characterization of novel sildenafil citrate loaded polyvinyl alcohol polyethylene glycol graft copolymer based orally dissolving films. Int J Pharm. 2014 Oct;473(1-2):398-406. doi: 10.1016/j.ijpharm.2014.07.037, PMID 25079431.
Nishigaki M, Kawahara K, Nawa M, Futamura M, Nishimura M, Matsuura K. Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness. Int J Pharm. 2012 Mar;424(1-2):12-7. doi: 10.1016/j.ijpharm.2011.12.057, PMID 22240389.
Elkanayati RM, Darwesh AY, Taha I, Wang H, Uttreja P, Vemula SK. Quality by design approach for fabrication of extended release buccal films for xerostomia employing hot melt extrusion technology. Eur J Pharm Biopharm. 2024 Jul;200:114335. doi: 10.1016/j.ejpb.2024.114335, PMID 38768765.
Shah B, Khunt D, Bhatt H, Misra M, Padh H. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci. 2015 Oct;78:54-66. doi: 10.1016/j.ejps.2015.07.002, PMID 26143262.
Shaikh MV, Kala M, Nivsarkar M. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using box-behnken design: ex-vivo stability and in vitro activity. Eur J Pharm Sci. 2017 Mar;100:262-72. doi: 10.1016/j.ejps.2017.01.026, PMID 28126560.
Camacho Vieira C, Peltonen L, Karttunen AP, Ribeiro AJ. Is it advantageous to use quality by design (QBD) to develop nanoparticle-based dosage forms for parenteral drug administration? Int J Pharm. May 2024;657:124163. doi: 10.1016/j.ijpharm.2024.124163, PMID 38670473.
Chakraborty A, Gupta A, Singh AK, Patni P. Effect of oxidative phytochemicals on nicotine-stressed UMNSAH/DF-1 cell line. J Tradit Complement Med. 2014 Apr;4(2):126-31. doi: 10.4103/2225-4110.126172, PMID 24860736.
Cosci F, Pistelli F, Lazzarini N, Carrozzi L. Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation. Psychol Res Behav Manag. 2011;4:119-28. doi: 10.2147/PRBM.S14243, PMID 22114542.
Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;3:CD006103. doi: 10.1002/14651858.
Pennington E, Bell S, Hill JE. Should video laryngoscopy or direct laryngoscopy be used for adults undergoing endotracheal intubation in the pre-hospital setting? A critical appraisal of a systematic review. J Paramed Pract. 2023;15(6):255-9. doi: 10.1002/14651858, PMID 38812899.
Nakajima M, Al Absi M. Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers. Psychophysiology. 2014;51(10):1015-22. doi: 10.1111/PSYP.12241, PMID 24934193.
Breslau N, Kilbey MM, Andreski P. Nicotine dependence major depression and anxiety in young adults. Arch Gen Psychiatry. 1991;48(12):1069-74. doi: 10.1001/ARCHPSYC.1991.01810360033005, PMID 1845224.
Covey LS. Tobacco cessation among patients with depression. Prim Care. 1999 Sep;26(3):691-706. doi: 10.1016/S0095-4543(05)70124-X, PMID 10436294.
IM, CP, NA, BS, RJ, C Youths. Bonnie. In: Lynch. The nature of nicotine addiction; 1994. Available from: https://www.ncbi.nlm.nih.gov/books/NBK236759. [Last accessed on 13 Jan 2025].
Shamsudeen S, Kakunje A. Comments on: comparative evaluation of the efficacy of nicotine chewing gum and nicotine patches as nicotine replacement therapy using salivary cotinine levels as a biochemical validation measure. Indian J Psychiatry. 2024 Mar;66(1):119-20. doi: 10.4103/indianjpsychiatry.Indianjpsychiatry_631_23, PMID 38419920.
Mallock N, Schulz T, Malke S, Dreiack N, Laux P, Luch A. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tob Control. 2024 Mar.;33(2):193-9. doi: 10.1136/TC-2022-057280, PMID 38378209.
Nicotine replacement therapy to help you quit tobacco. American Cancer Society. Available from: https://www.cancer.org/cancer/risk-prevention/tobacco/guide-quittingsmoking/nicotine-replacement-therapy.html. [Last accessed on 26 Mar 2025].
Wang Z, LI J, Yang H, SU X, Bushra R, Guo J. Optimized steam explosion treatment of tobacco stems for enhanced extraction of solanesol and nicotine. Ind Crops Prod. 2025 Mar;225:120470. doi: 10.1016/j.indcrop.2025.120470.
Agrupis S, Maekawa E, Suzuki K. Industrial utilization of tobacco stalks II: preparation and characterization of tobacco pulp by steam explosion pulping. J Wood Sci. 2000;46(3):222-9. doi: 10.1007/BF00776453.
Clayton PM, Vas CA, Bui TT, Drake AF, MC Adam K. Spectroscopic studies on nicotine and nornicotine in the UV region. Chirality. 2013 May;25(5):288-93. doi: 10.1002/CHIR.22141, PMID 23494810.
Sukweenadhi J, Tranku C, Ayu D, Kang SC. Optimizing nicotine extraction and analysis method from tobacco agrowaste extract. BIO Web Conf. 2024;104:00022. doi: 10.1051/bioconf/202410400022.
Fathi RM, Fauzantoro A, Rahman SF, Gozan M. Column chromatography isolation of nicotine from tobacco leaf extract (Nicotiana tabaccum L.). AIP Conf Proc. 2018;1927:030020. doi: 10.1063/1.5023958.
Barlow RB, Hamilton JT. The stereospecificity of nicotine. Br J Pharmacol Chemother. 1965;25(1):206-12. doi: 10.1111/j.1476-5381.1965.tb01773.x, PMID 19108199.
Yildiz D, Nicotine. Its metabolism and an overview of its biological effects. Toxicon. 2004 May;43(6):619-32. doi: 10.1016/j.toxicon.2004.01.017, PMID 15109883.
Clayton PM, Vas CA, Bui TT, Drake AF, MC Adam K. Spectroscopic studies on nicotine and nornicotine in the UV region. Chirality. 2013 May;25(5):288-93. doi: 10.1002/CHIR.22141, PMID 23494810.
Joseph A, Kumar GJ, Pawar SD, Hirlekar BU, Bharatam PV, Konda S. Analytical developments of p-hydroxy prenylamine reference material for dope control research: characterization and purity assessment. Drug Test Anal. 2022;14(2):224-32. doi: 10.1002/dta.3171, PMID 34617411.
Al Dahhan WH, Kadhom M, Yousif E, Mohammed SA, Alkaim A. Extraction and determination of nicotine in tobacco from selected local cigarettes brands in Iraq. Lett Appl Nano Bio Sci. 2021;11(1):3278-90. doi: 10.33263/LIANBS111.32783290.
Ning Y, Zhang LY, Mai J, SU JE, Cai JY, Chen Y. Tobacco microbial screening and application in improving the quality of tobacco in different physical states. Bioresour Bioprocess. 2023 Dec;10(1):32. doi: 10.1186/S40643-023-00651-6, PMID 38647749.
Pawar SD, Gawali K, Kulhari H, Murty US, Kumar P. Amoxapine loaded solid lipid nanoparticles with superior preclinical pharmacokinetics for better brain delivery: LC-MS/MS and GC-MS analysis. ACS Chem Neurosci. 2023;14(8):1388-98. doi: 10.1021/acschemneuro.2c00673, PMID 37027804.
Yang J, Liu ZH, Zhu RZ, Xiang NJ, Tang SY, HE P. X-ray powder diffraction data for nicotine 3,5-dihydroxybenzoate dihydrate, C10H15N2⋅C7H5O4⋅2H2O. Powder Diffr. 2021 Mar;36(1):25-8. doi: 10.1017/S0885715621000014.
Pawar SD, Gawali K, Jat S, Singh P, Datusalia AK, Kulhari H. Physiochemical characterization and pharmacokinetic assessment of bergamottin solid lipid nanoparticles. J Drug Deliv Sci Technol. 2024 Jan;93:105426. doi: 10.1016/j.jddst.2024.105426.
Singh C, Rao K, Yadav N, Bansal N, Vashist Y, Kumari S. A review: drug excipient incompatibility by ftir spectroscopy. Curr Pharm Anal. 2023 Feb;19(5):371-8. doi: 10.2174/1573412919666230228102158.
Suryawanshi D, Wavhule P, Shinde U, Kamble M, Amin P. Development optimization and in vivo evaluation of cyanocobalamin loaded orodispersible films using hot melt extrusion technology: a quality by design (QbD) approach. J Drug Deliv Sci Technol. 2021 Jun;63:102559. doi: 10.1016/j.jddst.2021.102559.
The place of drug product critical quality parameters in quality by design (QBD). Available from: https://www.researchgate.net/publication/281925128_The_place_of_drug_product_critical_quality_parameters_in_quality_by_design_QBD. [Last accessed on 01 Feb 2025].
Sanchez MF, Luciani Giacobbe LC, Barbieri F, Olivera ME. Defining critical quality attributes and composition parameters for burn wound dressings: antibiotic anesthetic films as a model. Heliyon. 2024 Nov;10(22):e39766. doi: 10.1016/j.heliyon.2024.e39766, PMID 39605837.
Bharti K, Mittal P, Mishra B. Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment. J Drug Deliv Sci Technol. 2019 Feb;49:420-32. doi: 10.1016/j.jddst.2018.12.013.
Priyanka, Kumar K, Teotia D. A comprehensive review on pharmaceutical oral dissolving films. J Drug Delivery Ther. 2019;9(5):170-4. doi: 10.22270/jddt.v9i5-s.3641.
Joshi P, Patel H, Patel V, Panchal R. Formulation development and evaluation of mouth dissolving film of domperidone. J Pharm Bioallied Sci. 2012 Mar;4 Suppl 1:S108-9. doi: 10.4103/0975-7406.94159, PMID 23066181.
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline stability testing of new drug substances and products Q1A(R2); 2003.
Taufik M, Ardilla D, Razali M, Susilawati E, Afniwati, Fadillah N. Extraction and analysis of nicotine from the saliva of active smokers using UV spectroscopy. In: proceedings of the 1st international mipanet conference on science and mathematics. Scitepress Science and Technology Publications; 2019. p. 616-20. doi: 10.5220/0010614700002775.
Mihranyan A, Andersson SB, EK R. Sorption of nicotine to cellulose powders. Eur J Pharm Sci. 2004 Jul;22(4):279-86. doi: 10.1016/j.ejps.2004.03.012, PMID 15196584.
Wang H, George G, Bartlett S, Gao C, Islam N. Nicotine hydrogen tartrate loaded chitosan nanoparticles: formulation characterization and in vitro delivery from dry powder inhaler formulation. Eur J Pharm Biopharm. 2017 Apr;113:118-31. doi: 10.1016/j.ejpb.2016.12.023, PMID 28088005.
LI ZQ, Shang SZ, Liao XX, Lei P, Han JM, YI B. X-ray powder diffraction data for nicotine 2,6-dihydroxybenzoate, C10H15N2⋅C7H5O4. Powder Diffr. 2022;37(2):105-7. doi: 10.1017/S0885715622000070.
Alaei S, Omidi Y, Omidian H. In vitro evaluation of adhesion and mechanical properties of oral thin films. Eur J Pharm Sci. 2021 Nov;166:105965. doi: 10.1016/j.ejps.2021.105965, PMID 34375679.
Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS Pharm Sci Tech. 2008 Jun;9(2):349-56. doi: 10.1208/s12249-008-9047-7, PMID 18431674.
Published
How to Cite
Issue
Section
Copyright (c) 2025 SACHIN DATTRAM PAWAR, NAGOJI SHINDE, GUNDAWAR RAVI, TUKARAM KALYANKAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
